Cargando…
Neural stem cell-like cells derived from autologous bone mesenchymal stem cells for the treatment of patients with cerebral palsy
BACKGROUND: Stem cell therapy is a promising treatment for cerebral palsy, which refers to a category of brain diseases that are associated with chronic motor disability in children. Autologous MSCs may be a better cell source and have been studied for the treatment of cerebral palsy because of thei...
Autores principales: | Chen, Guojun, Wang, Yali, Xu, Zhenyu, Fang, Feng, Xu, Renmei, Wang, Yue, Hu, Xiaoli, Fan, Lixing, Liu, Houqi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3563497/ https://www.ncbi.nlm.nih.gov/pubmed/23351389 http://dx.doi.org/10.1186/1479-5876-11-21 |
Ejemplares similares
-
Therapeutic Potential of Autologous Stem Cell Transplantation for Cerebral Palsy
por: Purandare, Chaitanya, et al.
Publicado: (2012) -
Acceptability of neural stem cell therapy for cerebral palsy: survey of the Australian cerebral palsy community
por: Smith, Madeleine J., et al.
Publicado: (2023) -
Prevention and treatment of cerebral palsy with cord blood stem cells and cord-derived mesenchymal stem cells
por: Shintaku, Haruo
Publicado: (2020) -
Treatment of one case of cerebral palsy combined with posterior visual pathway injury using autologous bone marrow mesenchymal stem cells
por: Li, Min, et al.
Publicado: (2012) -
MicroRNA-181 Regulates CARM1 and Histone Aginine Methylation to Promote Differentiation of Human Embryonic Stem Cells
por: Xu, Zhenyu, et al.
Publicado: (2013)